Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DECITABINE Cause Second primary malignancy? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Second primary malignancy have been filed in association with DECITABINE (Decitabine). This represents 0.2% of all adverse event reports for DECITABINE.

5
Reports of Second primary malignancy with DECITABINE
0.2%
of all DECITABINE reports
4
Deaths
2
Hospitalizations

How Dangerous Is Second primary malignancy From DECITABINE?

Of the 5 reports, 4 (80.0%) resulted in death, 2 (40.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.

Is Second primary malignancy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DECITABINE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does DECITABINE Cause?

Febrile neutropenia (336) Off label use (292) Drug ineffective (253) Pneumonia (243) Myelosuppression (233) Product use in unapproved indication (195) Neutropenia (193) Sepsis (175) Acute myeloid leukaemia (172) Thrombocytopenia (170)

What Other Drugs Cause Second primary malignancy?

CYCLOPHOSPHAMIDE (1,247) DOXORUBICIN (1,151) VINCRISTINE (908) IMATINIB (763) PALBOCICLIB (658) RITUXIMAB (646) RUXOLITINIB (611) ETOPOSIDE (573) PREDNISONE (517) OCTREOTIDE (496)

Which DECITABINE Alternatives Have Lower Second primary malignancy Risk?

DECITABINE vs DEFERASIROX DECITABINE vs DEFERIPRONE DECITABINE vs DEFEROXAMINE DECITABINE vs DEFIBROTIDE DECITABINE vs DEFLAZACORT

Related Pages

DECITABINE Full Profile All Second primary malignancy Reports All Drugs Causing Second primary malignancy DECITABINE Demographics